| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | GLI-SUFU complex | 1.32e-04 | 4 | 99 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | guanylate cyclase complex, soluble | 1.32e-04 | 4 | 99 | 2 | GO:0008074 | |
| Domain | Phosphofurin_acidic_CS-1 | 2.78e-05 | 2 | 99 | 2 | IPR019381 | |
| Domain | Pacs-1 | 2.78e-05 | 2 | 99 | 2 | PF10254 | |
| Domain | Tyr_Pase_non-rcpt_typ-14/21 | 2.78e-05 | 2 | 99 | 2 | IPR014392 | |
| Domain | PTPc | 3.84e-05 | 36 | 99 | 4 | SM00194 | |
| Domain | CarboxyPept_regulatory_dom | 3.98e-05 | 13 | 99 | 3 | IPR014766 | |
| Domain | - | 3.98e-05 | 13 | 99 | 3 | 2.60.40.1120 | |
| Domain | TYR_PHOSPHATASE_PTP | 5.30e-05 | 39 | 99 | 4 | PS50055 | |
| Domain | PTPase_domain | 6.47e-05 | 41 | 99 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 6.47e-05 | 41 | 99 | 4 | PF00102 | |
| Domain | CarboxyPept-like_regulatory | 9.31e-05 | 17 | 99 | 3 | IPR008969 | |
| Domain | Zn_pept | 1.11e-04 | 18 | 99 | 3 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.32e-04 | 19 | 99 | 3 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 1.54e-04 | 20 | 99 | 3 | PS00132 | |
| Domain | HNOB | 1.66e-04 | 4 | 99 | 2 | PF07700 | |
| Domain | Peptidase_M14 | 2.37e-04 | 23 | 99 | 3 | PF00246 | |
| Domain | Peptidase_M14 | 2.37e-04 | 23 | 99 | 3 | IPR000834 | |
| Domain | PTPc_motif | 2.70e-04 | 59 | 99 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.70e-04 | 59 | 99 | 4 | IPR003595 | |
| Domain | HNOB_dom_associated | 4.11e-04 | 6 | 99 | 2 | IPR011645 | |
| Domain | HNOBA | 4.11e-04 | 6 | 99 | 2 | PF07701 | |
| Domain | Tyr_Pase_AS | 6.11e-04 | 73 | 99 | 4 | IPR016130 | |
| Domain | Heme_NO-bd | 9.77e-04 | 9 | 99 | 2 | IPR011644 | |
| Domain | TYR_PHOSPHATASE_1 | 1.13e-03 | 86 | 99 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 1.18e-03 | 87 | 99 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.18e-03 | 87 | 99 | 4 | PS50056 | |
| Domain | LDLR_class-A_CS | 1.24e-03 | 40 | 99 | 3 | IPR023415 | |
| Domain | - | 1.45e-03 | 92 | 99 | 4 | 3.90.190.10 | |
| Domain | Ldl_recept_a | 1.74e-03 | 45 | 99 | 3 | PF00057 | |
| Domain | - | 1.86e-03 | 46 | 99 | 3 | 4.10.400.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.90e-03 | 99 | 99 | 4 | IPR029021 | |
| Domain | LDLRA_1 | 2.10e-03 | 48 | 99 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.23e-03 | 49 | 99 | 3 | IPR002172 | |
| Domain | LDLa | 2.23e-03 | 49 | 99 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.23e-03 | 49 | 99 | 3 | PS50068 | |
| Domain | uDENN | 2.43e-03 | 14 | 99 | 2 | SM00800 | |
| Domain | Ldl_recept_b | 2.43e-03 | 14 | 99 | 2 | PF00058 | |
| Domain | LDLRB | 2.43e-03 | 14 | 99 | 2 | PS51120 | |
| Domain | uDENN | 2.79e-03 | 15 | 99 | 2 | PF03456 | |
| Domain | LY | 2.79e-03 | 15 | 99 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.79e-03 | 15 | 99 | 2 | IPR000033 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | SM00799 | |
| Domain | MAM_1 | 3.18e-03 | 16 | 99 | 2 | PS00740 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | PF02141 | |
| Domain | dDENN | 3.18e-03 | 16 | 99 | 2 | PF03455 | |
| Domain | UDENN | 3.18e-03 | 16 | 99 | 2 | PS50946 | |
| Domain | DDENN | 3.18e-03 | 16 | 99 | 2 | PS50947 | |
| Domain | dDENN | 3.18e-03 | 16 | 99 | 2 | SM00801 | |
| Domain | dDENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR005113 | |
| Domain | DENN | 3.18e-03 | 16 | 99 | 2 | PS50211 | |
| Domain | DENN_dom | 3.18e-03 | 16 | 99 | 2 | IPR001194 | |
| Domain | ig | 3.42e-03 | 190 | 99 | 5 | PF00047 | |
| Domain | Immunoglobulin | 3.42e-03 | 190 | 99 | 5 | IPR013151 | |
| Domain | MAM | 3.59e-03 | 17 | 99 | 2 | SM00137 | |
| Domain | MAM | 4.03e-03 | 18 | 99 | 2 | PF00629 | |
| Domain | MAM_dom | 4.03e-03 | 18 | 99 | 2 | IPR000998 | |
| Domain | MAM_2 | 4.03e-03 | 18 | 99 | 2 | PS50060 | |
| Domain | Guanylate_cyc | 4.48e-03 | 19 | 99 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.48e-03 | 19 | 99 | 2 | PS50125 | |
| Domain | A/G_cyclase | 4.48e-03 | 19 | 99 | 2 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.48e-03 | 19 | 99 | 2 | PS00452 | |
| Domain | CYCc | 4.48e-03 | 19 | 99 | 2 | SM00044 | |
| Pubmed | 3.86e-07 | 21 | 101 | 4 | 22932696 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 22431569 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.01e-06 | 180 | 101 | 7 | 35198878 | |
| Pubmed | 1.73e-06 | 30 | 101 | 4 | 24073291 | ||
| Pubmed | Expression of signaling components in embryonic eyelid epithelium. | 2.81e-06 | 10 | 101 | 3 | 24498290 | |
| Pubmed | ERBB2 VPS39 CACHD1 SLC7A6 AGO4 RBM27 MORF4L2 MED12L PAN2 IGSF1 | 3.39e-06 | 529 | 101 | 10 | 14621295 | |
| Pubmed | Complementary Gli activity mediates early patterning of the mouse visual system. | 3.86e-06 | 11 | 101 | 3 | 16342201 | |
| Pubmed | Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina. | 5.13e-06 | 12 | 101 | 3 | 18417110 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN ERBB2 ARHGAP10 SHROOM2 HNRNPL PACS1 TLK1 PXDN GTF3C1 UBE2H GLI2 NECTIN2 LRP5 GREB1 DENND5A MAPK6 | 6.05e-06 | 1489 | 101 | 16 | 28611215 |
| Pubmed | 8.19e-06 | 162 | 101 | 6 | 25826454 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 33125874 | ||
| Pubmed | Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target. | 8.35e-06 | 2 | 101 | 2 | 29321573 | |
| Pubmed | Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling. | 8.35e-06 | 2 | 101 | 2 | 27893742 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16888092 | ||
| Pubmed | ErbB2 induces Notch1 activity and function in breast cancer cells. | 8.35e-06 | 2 | 101 | 2 | 20443831 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25745035 | ||
| Pubmed | Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes. | 8.35e-06 | 2 | 101 | 2 | 30695055 | |
| Pubmed | Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. | 8.35e-06 | 2 | 101 | 2 | 12165851 | |
| Pubmed | The GLI gene is a member of the Kruppel family of zinc finger proteins. | 8.35e-06 | 2 | 101 | 2 | 2832761 | |
| Pubmed | GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression. | 8.35e-06 | 2 | 101 | 2 | 32766732 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35251038 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15175043 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22496420 | ||
| Pubmed | [Expression and clinical significances of hedgehog signaling pathway in non-Hodgkin's lymphoma]. | 8.35e-06 | 2 | 101 | 2 | 22040957 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28476937 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18469855 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23792444 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29686309 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20459529 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23923007 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24418624 | ||
| Pubmed | MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts. | 8.35e-06 | 2 | 101 | 2 | 19578738 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25681440 | ||
| Pubmed | Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. | 8.35e-06 | 2 | 101 | 2 | 19956862 | |
| Pubmed | HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. | 8.35e-06 | 2 | 101 | 2 | 30409762 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26526577 | ||
| Pubmed | Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. | 8.35e-06 | 2 | 101 | 2 | 16434164 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23766685 | ||
| Pubmed | 1.30e-05 | 16 | 101 | 3 | 9655799 | ||
| Pubmed | 1.57e-05 | 17 | 101 | 3 | 28778798 | ||
| Pubmed | 1.88e-05 | 18 | 101 | 3 | 14723851 | ||
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 2.23e-05 | 19 | 101 | 3 | 28916710 | |
| Pubmed | 2.23e-05 | 19 | 101 | 3 | 29166577 | ||
| Pubmed | Cell Cycle-Related Kinase (CCRK) regulates ciliogenesis and Hedgehog signaling in mice. | 2.23e-05 | 19 | 101 | 3 | 28817564 | |
| Pubmed | Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins. | 2.50e-05 | 3 | 101 | 2 | 30802137 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26010061 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 28342001 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 23341344 | ||
| Pubmed | The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. | 2.50e-05 | 3 | 101 | 2 | 30382189 | |
| Pubmed | Effect of Rab23 on the proliferation and apoptosis in breast cancer. | 2.50e-05 | 3 | 101 | 2 | 26238143 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 37541211 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26193634 | ||
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 2.50e-05 | 3 | 101 | 2 | 36169302 | |
| Pubmed | The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells. | 2.50e-05 | 3 | 101 | 2 | 28393230 | |
| Pubmed | Sp1 and KLF15 regulate basal transcription of the human LRP5 gene. | 2.50e-05 | 3 | 101 | 2 | 20141633 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 29743588 | ||
| Pubmed | UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. | 2.50e-05 | 3 | 101 | 2 | 26449661 | |
| Pubmed | Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1. | 2.50e-05 | 3 | 101 | 2 | 29895705 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17611666 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 24217340 | ||
| Pubmed | IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. | 2.50e-05 | 3 | 101 | 2 | 30368528 | |
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 2.50e-05 | 3 | 101 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 2.50e-05 | 3 | 101 | 2 | 8378770 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33369122 | ||
| Pubmed | The effects of Gli1 and Gli2 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. | 2.50e-05 | 3 | 101 | 2 | 37478645 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 31560714 | ||
| Pubmed | Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma. | 2.50e-05 | 3 | 101 | 2 | 32108992 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 25888497 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17613170 | ||
| Pubmed | Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG. | 2.50e-05 | 3 | 101 | 2 | 33313950 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 8387379 | ||
| Pubmed | GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray. | 2.50e-05 | 3 | 101 | 2 | 25667444 | |
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 2.50e-05 | 3 | 101 | 2 | 16571352 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12068298 | ||
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 2.50e-05 | 3 | 101 | 2 | 22178118 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 23178452 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 30666517 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32879407 | ||
| Pubmed | Gli1 is important for medulloblastoma formation in Ptc1+/- mice. | 2.50e-05 | 3 | 101 | 2 | 15806168 | |
| Pubmed | [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients]. | 2.50e-05 | 3 | 101 | 2 | 22490851 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21993452 | ||
| Pubmed | SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines. | 2.50e-05 | 3 | 101 | 2 | 26588701 | |
| Pubmed | 3.04e-05 | 21 | 101 | 3 | 24198274 | ||
| Pubmed | 3.04e-05 | 21 | 101 | 3 | 17303760 | ||
| Pubmed | 3.04e-05 | 21 | 101 | 3 | 32169553 | ||
| Pubmed | 3.52e-05 | 22 | 101 | 3 | 15215207 | ||
| Pubmed | 3.52e-05 | 22 | 101 | 3 | 21775418 | ||
| Pubmed | 4.04e-05 | 23 | 101 | 3 | 31226309 | ||
| Pubmed | 4.60e-05 | 24 | 101 | 3 | 21633169 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 9027508 | ||
| Pubmed | RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice. | 4.99e-05 | 4 | 101 | 2 | 36747781 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 22281533 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 27793025 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 15793308 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 27760825 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 20970160 | ||
| Pubmed | Expression profile of Gli family members and Shh in normal and mutant mouse limb development. | 4.99e-05 | 4 | 101 | 2 | 9438426 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 8150204 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 23086478 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 10531011 | ||
| Interaction | CTDSPL interactions | 6.48e-06 | 92 | 100 | 6 | int:CTDSPL | |
| Cytoband | 3q21.3 | 1.37e-04 | 45 | 101 | 3 | 3q21.3 | |
| GeneFamily | Carboxypeptidases | 7.97e-05 | 21 | 73 | 3 | 1321 | |
| GeneFamily | Guanylate cyclases, soluble | 9.60e-05 | 4 | 73 | 2 | 820 | |
| GeneFamily | Immunoglobulin like domain containing | 1.10e-03 | 193 | 73 | 5 | 594 | |
| GeneFamily | Low density lipoprotein receptors | 1.22e-03 | 13 | 73 | 2 | 634 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.36e-03 | 18 | 73 | 2 | 812 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.21e-03 | 21 | 73 | 2 | 813 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.54e-03 | 25 | 73 | 2 | 504 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB2 ARHGAP10 GATA6 PTPRU RUNX1 PTPN14 IGFBP2 PLPP2 GLI2 NECTIN2 CPXM1 LRP5 CLSPN MYO16 NOTCH1 DNAH11 | 2.99e-06 | 1074 | 100 | 16 | M1941 |
| Coexpression | ERBB2_UP.V1_UP | 8.54e-06 | 190 | 100 | 7 | M2636 | |
| Coexpression | MEK_UP.V1_UP | 1.01e-05 | 195 | 100 | 7 | M2725 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.57e-05 | 114 | 99 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-07 | 172 | 101 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-07 | 183 | 101 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 199 | 101 | 7 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 3.06e-06 | 176 | 101 | 6 | 9c1f255de3082b3da4bef2a9bdff710cfd48261f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-06 | 177 | 101 | 6 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-06 | 177 | 101 | 6 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 179 | 101 | 6 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 179 | 101 | 6 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 179 | 101 | 6 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-06 | 182 | 101 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 185 | 101 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 185 | 101 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 186 | 101 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 188 | 101 | 6 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-06 | 188 | 101 | 6 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 4.76e-06 | 190 | 101 | 6 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.91e-06 | 191 | 101 | 6 | 68b717fce7d9349ef56255ee0c5e57fc67e50fd8 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 191 | 101 | 6 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 192 | 101 | 6 | 9e031bf93eb8757fdd0cc22f01b44e48f85532d5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 192 | 101 | 6 | 3d777d07878269b87ec7e1f06489cae7c989d633 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.06e-06 | 192 | 101 | 6 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.06e-06 | 192 | 101 | 6 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-06 | 193 | 101 | 6 | 371f4c98a599923fbe8382530b3eab05d873665a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.36e-06 | 194 | 101 | 6 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.36e-06 | 194 | 101 | 6 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-06 | 195 | 101 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-06 | 195 | 101 | 6 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-06 | 195 | 101 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 196 | 101 | 6 | 429de4119c8b2193c992d36a6af84f806730cbee | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 196 | 101 | 6 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-06 | 196 | 101 | 6 | 8c8a73d9d9581b8d9a9babfa93459d12fb9eb3ac | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-06 | 197 | 101 | 6 | 6806ec223e542f0475303698eb78c1cc527f5c6b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 198 | 101 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.21e-06 | 199 | 101 | 6 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.21e-06 | 199 | 101 | 6 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.21e-06 | 199 | 101 | 6 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | (1)_T_cell-(16)_Tfh|(1)_T_cell / shred on Cell_type and subtype | 6.39e-06 | 200 | 101 | 6 | 3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.39e-06 | 200 | 101 | 6 | 41705bbba40eb5ddca0b223191aac1bce00163b8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 200 | 101 | 6 | 741e59c68ae4a3a7be830e98771a14f920c9e883 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 200 | 101 | 6 | 55b7b17f2d413b9ebb262ef8bd210ef45618a7f3 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.39e-06 | 200 | 101 | 6 | 53e04399d0308b40ae99fbfaa4ff62bf061822d8 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.39e-06 | 200 | 101 | 6 | cc8df398532c9324fd3e171000b1ea5c208cd691 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 6.39e-06 | 200 | 101 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 1.18e-05 | 130 | 101 | 5 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-05 | 156 | 101 | 5 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-05 | 161 | 101 | 5 | 0e2b54a63781397f6b99eb0e201fbb820cbd7cc6 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-05 | 164 | 101 | 5 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 3.72e-05 | 165 | 101 | 5 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 165 | 101 | 5 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 166 | 101 | 5 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 167 | 101 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.06e-05 | 168 | 101 | 5 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 169 | 101 | 5 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 169 | 101 | 5 | e9c0e0f4c421c7bdbf1a7e33002f3cf22ea307cb | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 4.17e-05 | 169 | 101 | 5 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 169 | 101 | 5 | d375a1df1ecc938f66bad92e54b8cda26ca9c472 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 169 | 101 | 5 | 58f805c0be507bd5fadc9ea3555032daabbc8ab8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 170 | 101 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.29e-05 | 170 | 101 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 173 | 101 | 5 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 174 | 101 | 5 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 174 | 101 | 5 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 174 | 101 | 5 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.79e-05 | 174 | 101 | 5 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-05 | 176 | 101 | 5 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-05 | 176 | 101 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.20e-05 | 177 | 101 | 5 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 5.20e-05 | 177 | 101 | 5 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.20e-05 | 177 | 101 | 5 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.48e-05 | 179 | 101 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 5.63e-05 | 180 | 101 | 5 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-05 | 180 | 101 | 5 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 180 | 101 | 5 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-05 | 180 | 101 | 5 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.93e-05 | 182 | 101 | 5 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 5.93e-05 | 182 | 101 | 5 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 182 | 101 | 5 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.09e-05 | 183 | 101 | 5 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 6.09e-05 | 183 | 101 | 5 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.09e-05 | 183 | 101 | 5 | 031b4ffd95114dc10d2932c67d2cfef139b3fd2e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-05 | 183 | 101 | 5 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.09e-05 | 183 | 101 | 5 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.41e-05 | 185 | 101 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-05 | 185 | 101 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-05 | 185 | 101 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-05 | 185 | 101 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 6.41e-05 | 185 | 101 | 5 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.57e-05 | 186 | 101 | 5 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.57e-05 | 186 | 101 | 5 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.57e-05 | 186 | 101 | 5 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.57e-05 | 186 | 101 | 5 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.74e-05 | 187 | 101 | 5 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.74e-05 | 187 | 101 | 5 | baff4edc1bf64e3e03864a434fa47075ff7372fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 187 | 101 | 5 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| Disease | heart valve disease (is_marker_for) | 3.07e-05 | 3 | 95 | 2 | DOID:4079 (is_marker_for) | |
| Disease | response to thiazide, low density lipoprotein cholesterol measurement | 3.07e-05 | 3 | 95 | 2 | EFO_0004611, EFO_0007981 | |
| Disease | Malignant neoplasm of breast | ERBB2 VPS39 SH2D3A SHROOM2 MAMDC4 HNRNPL PTPN14 GLI1 NECTIN2 LGR6 MMP2 CLSPN NOTCH1 | 4.02e-05 | 1074 | 95 | 13 | C0006142 |
| Disease | gamma-glutamyl-alpha-lysine measurement | 6.13e-05 | 4 | 95 | 2 | EFO_0800689 | |
| Disease | Pigmented Basal Cell Carcinoma | 9.99e-05 | 28 | 95 | 3 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.11e-04 | 29 | 95 | 3 | C4721806 | |
| Disease | serine:glycine ratio | 2.13e-04 | 7 | 95 | 2 | EFO_0021777 | |
| Disease | basal cell adhesion molecule measurement | 2.84e-04 | 8 | 95 | 2 | EFO_0008032 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | smoking behaviour measurement, waist-hip ratio | 5.54e-04 | 11 | 95 | 2 | EFO_0004343, EFO_0005671 | |
| Disease | gallbladder cancer (is_implicated_in) | 7.82e-04 | 13 | 95 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | urate measurement, bone density | 8.80e-04 | 619 | 95 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Liver Cirrhosis, Experimental | 8.84e-04 | 774 | 95 | 9 | C0023893 | |
| Disease | Bladder Neoplasm | 1.11e-03 | 140 | 95 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.14e-03 | 141 | 95 | 4 | C0005684 | |
| Disease | endometriosis (biomarker_via_orthology) | 1.20e-03 | 16 | 95 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 1.35e-03 | 17 | 95 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.35e-03 | 17 | 95 | 2 | DOID:11984 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 1.56e-03 | 525 | 95 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.56e-03 | 525 | 95 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 1.59e-03 | 527 | 95 | 7 | C1458155 | |
| Disease | alkaline phosphatase measurement | ARHGAP10 KLF15 RUNX1 TLK1 PMPCA FCGR2B NECTIN2 BCAM UBASH3B NOTCH1 | 1.60e-03 | 1015 | 95 | 10 | EFO_0004533 |
| Disease | stomach cancer (is_implicated_in) | 1.64e-03 | 72 | 95 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 1.69e-03 | 19 | 95 | 2 | DOID:2876 (is_marker_for) | |
| Disease | C-reactive protein measurement | RNF144B ARHGAP10 KLF15 CACHD1 PACS1 TLK1 PXDN NECTIN2 BCAM MAPK6 DNAH11 | 1.72e-03 | 1206 | 95 | 11 | EFO_0004458 |
| Disease | Breast Carcinoma | 1.79e-03 | 538 | 95 | 7 | C0678222 | |
| Disease | maximal midexpiratory flow rate | 1.88e-03 | 20 | 95 | 2 | EFO_0004313 | |
| Disease | Glioblastoma | 2.14e-03 | 79 | 95 | 3 | C0017636 | |
| Disease | Nasopharyngeal carcinoma | 2.27e-03 | 22 | 95 | 2 | C2931822 | |
| Disease | Giant Cell Glioblastoma | 2.55e-03 | 84 | 95 | 3 | C0334588 | |
| Disease | congenital heart disease (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Dyslipidemias | 2.70e-03 | 24 | 95 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.70e-03 | 24 | 95 | 2 | C0598784 | |
| Disease | age at menarche | 3.11e-03 | 594 | 95 | 7 | EFO_0004703 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0004612, MONDO_0004975 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGTYHFRMTILPPLE | 461 | P24298 | |
| HYMVVDTSPDALPRG | 856 | Q6UXC1 | |
| PASPETHLDMLRHLY | 36 | P04626 | |
| APGYHSIVQRPMDLS | 741 | Q9H0E9 | |
| GMLLSYSHSELPQRP | 621 | Q12774 | |
| AMHLHLSGVRYPPEL | 296 | Q14687 | |
| TYSLLMHPDALEEPD | 291 | P31994 | |
| DDKGYTLMHPSLTRP | 511 | Q5VU97 | |
| RIHLLPSMNPDGYEI | 396 | Q96SM3 | |
| EEMLPPESPALYGLH | 4196 | Q96DT5 | |
| ARSPEDEYELLMPHR | 141 | Q8N6F7 | |
| AMLTLGPEVHPDTIY | 166 | P31146 | |
| YTAHPLPIGRDRVDM | 91 | Q9HCK5 | |
| APMPYLIGVHASLAE | 261 | Q8IV53 | |
| LEHSQDPGALMAPIY | 411 | P08253 | |
| HMATIEALRPYQPLG | 141 | Q9Y5Y2 | |
| LVPPRNLMGSSIGYH | 456 | Q9P2N5 | |
| GHYSFSMRSPELALP | 31 | P28062 | |
| RLHYLAMTAENPTPG | 6 | Q7Z419 | |
| LPEPLMTYELHGDFI | 466 | A1A4S6 | |
| LDPGLAEYAPAMHSA | 6 | Q504Q3 | |
| STMIHYLGPEDSLRP | 406 | Q5VV17 | |
| IEHDPRMPAYIATQG | 771 | Q16849 | |
| MLSPVDSLESPHGYL | 2196 | P46531 | |
| AMEHPRAIALDPRYG | 1376 | Q9NZR2 | |
| AYPAAHSNPVLMERL | 1971 | Q86YW9 | |
| GMDPHGESLPRSLRY | 1031 | Q4ZG55 | |
| PGDLDPLTAYLDLSM | 61 | Q9HBX8 | |
| VYIEMLGHAARPDSP | 1411 | Q9Y6X6 | |
| PTAATDMGALPIHYA | 131 | B1AK53 | |
| DQPRAIALDPAHGYM | 151 | O75197 | |
| TYAMRVLFPGIEDHP | 1326 | Q9UIW2 | |
| MRLPDERGPLEHLYS | 241 | P18065 | |
| GSREYPAGHPFLLMS | 191 | Q96DT0 | |
| PMDRLTAEEALSHPY | 301 | Q16659 | |
| DLLPGYLNDIPRHGM | 286 | O60662 | |
| LLAHPDAPMSQVYGA | 211 | Q15014 | |
| DAPMSQVYGAPHLLR | 216 | Q15014 | |
| MGLPTPEDNLDHYRN | 671 | P27487 | |
| SSLPGLMPAQHYLLR | 576 | P08151 | |
| TLVAGHPAPYGDLLM | 181 | P10070 | |
| DHLATIYPGMRAPSF | 106 | Q02153 | |
| SSENHLDPGPIYMRE | 6 | Q9Y546 | |
| GYLTRPHLVAMDPAA | 91 | Q96FT7 | |
| LETENYGPMHSVPSR | 686 | Q6IE36 | |
| YMRFLVIPLGSHPVA | 581 | Q86VP3 | |
| PYRPDTITHGLMAGV | 46 | O43688 | |
| RTDPIQMPYGDVLIH | 101 | O15442 | |
| QPDPAIGVHLMDRYT | 236 | Q92643 | |
| YMRFLIIPLGSHPVA | 656 | Q6VY07 | |
| RAPADLPHGSYLMVN | 61 | Q92729 | |
| ITGSDVMRPDYLPSH | 421 | Q16825 | |
| PIEMHSHDPLRYVGD | 296 | Q9Y2V7 | |
| TTRVGSMLPGLPYHL | 191 | Q92908 | |
| SHRSEPLKLMGPAGY | 496 | Q8N6C5 | |
| ALMTLGPSVVRYHLP | 561 | Q9P2D3 | |
| SLAPMDAPRYQHGIA | 371 | Q9P2N7 | |
| TRIHILPSMNPDGYE | 121 | P15169 | |
| HLLPSMNPDGYEVAA | 286 | Q66K79 | |
| LEGMLPPYLSACLDH | 56 | Q96CD0 | |
| PVPYLMGLHSNGLDD | 356 | Q6IQ26 | |
| GPHADSPVLMVYGLD | 376 | P14866 | |
| PPAEAYARMGHALEE | 136 | O75525 | |
| LVGRRAYHMLPSPVS | 26 | Q9UIH9 | |
| PPASLHAVLDMYLLD | 751 | Q8WYP5 | |
| TMHDTRGRSPPYQLD | 91 | P50895 | |
| GDLIHLPPYLRMDFL | 1896 | O60469 | |
| ALPSISDPRMHYPGA | 311 | Q01196 | |
| PEPLLTEMIHEAAYR | 201 | Q10713 | |
| SDRTSPYDHMLPGAE | 66 | P25325 | |
| GMEAPLSHLESRYLP | 201 | Q9NQ40 | |
| RPSHFYTDGPLMPSD | 836 | P52630 | |
| GILGPKMLTRHYDPS | 256 | A6NJY1 | |
| PAEEIPAYMSVHRLL | 451 | Q9Y4C2 | |
| MPIDYRGDRTTPLHS | 241 | A6NCL1 | |
| LGEYSMSSRPLHPVL | 511 | Q587J7 | |
| APRNMLSGYAEPAHI | 106 | O60508 | |
| GHLMNTFEPIYPERL | 171 | O75343 | |
| PGSDIMRADYIPSHR | 416 | Q15678 | |
| APSRPALLYMAALGA | 141 | Q587I9 | |
| PGDLYPESLEHRMGD | 706 | Q13796 | |
| ELGPSMAPEDHYRRL | 181 | Q96NU1 | |
| PIRYTPDGHLALMSQ | 171 | Q9BYC2 | |
| PMEIISAPRHGSIIY | 91 | O75891 | |
| TLYVHLQPGMSLEGP | 36 | Q13057 | |
| LIRESALNLPYHMPE | 296 | Q9HAW4 | |
| SLMPTDVVYVRLGPH | 121 | Q8IV77 | |
| DPYLLPHMRRSNSSG | 731 | Q9UKI8 | |
| PLNGDAAAMYLHRPE | 121 | P62256 | |
| PSIPALVHSYMTGRR | 86 | Q9BRG2 | |
| TMLVGRYPFHDIEPS | 246 | Q92519 | |
| LYNGHALPMPRLVST | 786 | Q92626 | |
| MHRLPPYSAGDGAEL | 336 | Q8IUF8 | |
| MEAREPGRPTPTYHL | 1 | Q92536 | |
| EGFRLYRPHLAPMSI | 481 | P42681 | |
| HPSPLGMAAREELYS | 6 | Q8TF42 | |
| DPSYGPLLMPSVHAA | 256 | A8MV65 | |
| MTRPGIPESSLLRHY | 2011 | Q12789 | |
| DIPASPQLLTDGHYM | 146 | Q9BT76 | |
| PQLLTDGHYMTLPLS | 151 | Q9BT76 | |
| PTHVMGLYPDLLPTD | 376 | Q96JC1 | |
| LYGAMVRHSIPLPES | 221 | P58304 | |
| MPRYHELPTLEERSG | 451 | Q92692 |